Related Experiment Video
Updated: Mar 5, 2026

Glutamine Flux Imaging Using Genetically Encoded Sensors
Published on: July 31, 2014
Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction
Jun-Kai Yan1,2,3, Ke-Jun Zhou1,2,3, Jian-Hu Huang1
1Department of Pediatric Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Rd, Shanghai, 200092, China.
Insights
Diagnosing chronic intestinal pseudo-obstruction (CIPO) in children is challenging. A new urinary biomarker, the glutamine to glutamic acid ratio, shows promise for differentiating CIPO from short bowel syndrome (SBS).
Area of Science:
- Pediatric Gastroenterology
- Biomarker Discovery
- Gastrointestinal Motility Disorders
Background:
- Chronic intestinal pseudo-obstruction (CIPO) is a rare pediatric motility disorder with severe outcomes.
- CIPO diagnosis is challenging due to overlapping symptoms with conditions like short bowel syndrome (SBS).
- Reliable and accessible diagnostic markers for CIPO are needed.
Discussion:
- This study investigated the potential of urinary amino acid ratios as diagnostic markers for CIPO.
- The ratio of glutamine to glutamic acid was identified as a promising candidate biomarker.
- This ratio may help differentiate CIPO from SBS in pediatric patients.
Key Insights:
- The glutamine/glutamic acid ratio demonstrated an area under the ROC curve of 0.83.
- A cutoff value of 7.04 achieved 65% sensitivity and 92% specificity in distinguishing CIPO from SBS.
- This urinary biomarker offers a potential tool for improving CIPO diagnosis.
Outlook:
- Further validation studies are required to confirm the utility of this biomarker in clinical practice.
- This discovery could lead to earlier and more accurate diagnosis of CIPO in children.
- Development of novel diagnostic strategies for rare gastrointestinal motility disorders is crucial.
Abstract:
Chronic intestinal pseudo-obstruction (CIPO) is a rare intestinal motility disorder with significant morbidity and mortality in pediatric patients. The diagnosis of CIPO is difficult, because it is clinically based on the symptoms and signs of bowel obstruction which are similar to the clinical manifestations of other gastrointestinal diseases like short bowel syndrome (SBS). Therefore, it is desirable to identify and establish new laboratory diagnostic markers for CIPO that are reliable and easily accessible. In our study we have identified the ratio of the urinary glutamine and glutamic acid as a promising biomarker for distinguishing suspected CIPO cases and simple SBS cases. The area under ROC curve was 0.83, at cutoff value = 7.04 with sensitivity of 65% and specificity of 92%.
More Related Videos
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Serum Studies: Renal Function Tests